asepticSU™ single use technology eliminates cleaning validation
27 April 2016 | By Watson-Marlow Fluid Technology Group
Cleaning validation has been eliminated, traceability simplified and filling accuracy enhanced...
List view / Grid view
27 April 2016 | By Watson-Marlow Fluid Technology Group
Cleaning validation has been eliminated, traceability simplified and filling accuracy enhanced...
11 April 2016 | By Victoria White, Digital Content Producer
The first cancer patient in Europe has been scanned with a imaging technique that could enable doctors to see whether a drug is working within a day of starting treatment...
11 March 2016 | By Victoria White
A trial has shown that lapatinib plus trastuzumab before surgery shrinks and may even destroy tumours in women with HER2+ breast cancer within 11 days. The EPHOS B trial studied 257 women with HER2 positive breast cancer in the short gap between initial diagnosis and surgery to remove their tumours.…
4 March 2016 | By Victoria White
Researchers have found the tools necessary to give immunotherapy the precision guidance that patients with cancer so desperately need...
4 November 2015 | By New England BioLabs, Inc.
New Ultra II technology addresses lower input amounts and challenging sample types for Illumina® next generation sequencing systems...
4 November 2015 | By Victoria White
Scientists have shown that tumour DNA shed into the bloodstream can be used to track cancers in real time as they evolve and respond to treatment...
17 September 2015 | By Andor
Andor Komet software characterises ‘Comets’ to detect Cancer...
9 July 2015 | By Victoria White
Around half of all breast cancer patients could one day benefit from having the cheap and widely-available hormone progesterone added to their treatment...
5 May 2015 | By Victoria White
A patient has become the first to receive a new ‘resistance-busting’ panRAF inhibitor with the launch of a phase I clinical trial...
9 April 2015 | By Victoria White
Genetic screening could improve doctors’ ability to work out which women are at increased risk of developing breast cancer, a major study has shown...
25 September 2014 | By AstraZeneca
AstraZeneca announced that MedImmune, its global biologics research and development arm, and Cancer Research UK, with its commercial arm, Cancer Research Technology (CRT), have entered into an innovative collaboration to establish a joint laboratory in Cambridge, UK...
20 May 2014 | By Cancer Research UK
CANCER RESEARCH UK scientists have shown how switching off a key protein in pancreatic cells slows the spread of the disease to other tissues, a key step which can mean patients have just weeks to live...
28 March 2014 | By Cancer Research Technology (CRT)
A new cancer drug, based on further development of a discovery originally made by Cancer Research UK, has entered a clinical trial to target a wide range of cancers.
26 March 2014 | By Cancer Research UK
Cancer Research UK’s Drug Development Office has launched a trial of a vaccine to treat some forms of cancer caused by a common virus known as the Epstein Barr Virus...
27 September 2013 | By Cancer Research UK
A US-led initiative to map the molecular similarities and differences of thousands of tumours has revealed new ways to classify cancer...